Article Information
PubMed
History
- Received March 23, 2015
- Accepted March 6, 2015
- Published online April 20, 2015.
Article Versions
- Latest version (March 23, 2015 - 08:29).
- Latest version (March 30, 2015 - 08:21).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2015 Canadian Medical Association or its licensors
Author Information
- Fiona McQuaid, MBBS⇑,
- Matthew D. Snape, MBBS MD,
- Tessa M. John, BSc,
- Sarah Kelly, MSc,
- Hannah Robinson, RN,
- Ly-Mee Yu, MSc,
- Daniela Toneatto, MD,
- Diego D’Agostino, MSc,
- Peter M. Dull, MD,
- Andrew J. Pollard, PhD
- Oxford Vaccine Group, Department of Paediatrics (McQuaid, Snape, John, Kelly, Robinson, Pollard), and Nuffield Department of Primary Care Health Sciences (Yu), University of Oxford, Oxford, UK; Oxford Biomedical Research Centre (McQuaid, Snape, John, Kelly, Robinson, Pollard), National Institute for Health Research, Oxford, UK; Novartis Vaccines and Diagnostics S.r.l. (Toneatto), Siena, Italy; Novartis Pharma BV (D’Agostino), Amsterdam, Netherlands; Novartis Vaccines and Diagnostics Inc. (Dull), Cambridge, Mass.
- Correspondence to: Fiona McQuaid, fiona.mcquaid{at}ed.ac.uk